Active's implants react to the body's movements in a way which enables them to mimic the flexibility of the original cartilage.
Active Implant Corporation (AIC), which is developing orthopedic implants, has completed clinical trials for its flagship product and received CE Mark certification which allows it to market the product in Europe. AIC is registered in Delaware, USA, its headquarters are located in Tennessee, where most of its investors also reside, and it has a development center in Netanya. The company is currently beginning gradual marketing in Europe. AIC was founded in Israel in 2004 by chairman and VP technology Amiram Steinberg, one of the founders of Impliant Ltd. (formerly Limber Ltd.) and DISCure Ltd.
The company's products are polymer implants intended for orthopedic use as substitutes for bone and cartilage. Active's implants react to the bodies movements in a way which enables them to mimic the flexibility of the original cartilage. The product which was approved is an implant intended for the hip-joints.
A number of months ago, AIC reported the completion of its first financing round, in which it raised $10 million, mostly from private strategic investors from Tennessee.
Published by Globes [online], Israel business news - www.globes.co.il - on September 19, 2006
© Copyright of Globes Publisher Itonut (1983) Ltd. 2006